Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal, and Latin America.
Second asset of the cannabis sector analyzed. Bullish divergence on the daily timeframe flanked by a double top that heralds a probable bullish bottom. Target price $ 17 - $ 21. Take into account the riskiness of the sector when managing this asset. Plenty of room for maneuver for various investment strategies.